An Openâ??Label, Two Arm Clinical Study to Evaluate the Efficacy and Safety of RUMA Spray in Acute Musculoskeletal Pain and Acute Sports Injury Pain Relief

The Himalaya Drug Company0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects of either gender aged >=18 - <=65 years.
•2.Subjects with Grade I and Grade II muscular sprains and joint pain.
•3.Subjects suffering from Common musculoskeletal conditions - Back ache, joints pain (Wrist, elbow, shoulder, ankle, Knee, neck pain, sprains and strains / Sports and traumatic injuries.
•4.Subjects willing to sign informed consent and follow with the schedule.
•5.Subjects who have not participated in similar kind of study in last 4 weeks.

•1.subjects suffering from auto-immune disorders, spastic disorders, genetic disorders and severe traumatic conditions.
•2.Any evidence or history of hypersensitivity to any of the components in the RUMA Spray
•3.Any known skin disorder or presence of open wounds.
•4.subjects who are taking any additional topical therapy or systemic NSAIDs.
•5.Clinical diagnosis of bruises, trauma, muscle damage.
•6.subjects with raw wounds, sutures, fractures and hematoma.
•7.Pregnant or lactating women/women not willing to follow adequate standard contraceptive measures.

发起方